Free Access
Med Sci (Paris)
Volume 33, Number 10, Octobre 2017
Page(s) 825 - 828
Section Nouvelles
Published online 10 October 2017
  1. Eckert C, Barbut F. Infections associées à Clostridium difficile. Med Sci (Paris) 2010 ; 26 : 153–158. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Bouza E. Consequences of Clostridium difficile infection: understanding the healthcare burden. Clin Microbiol Infect 2012 ; 18 (suppl 6) : 5–12. [CrossRef] [PubMed] [Google Scholar]
  3. Davies KA, Longshaw CM, Davis GL, et al. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis 2014 ; 14 : 1208–1219. [CrossRef] [PubMed] [Google Scholar]
  4. Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015 ; 372 : 825–834. [CrossRef] [PubMed] [Google Scholar]
  5. Martin JS, Monaghan TM, Wilcox MH. Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat Rev Gastroenterol Hepatol 2016 ; 13 : 206–216. [CrossRef] [PubMed] [Google Scholar]
  6. Buffie CG, Bucci V, Stein RR, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2015 ; 517 : 205–208. [CrossRef] [PubMed] [Google Scholar]
  7. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009 ; 7 : 526–536. [CrossRef] [PubMed] [Google Scholar]
  8. Chen X, Katchar K, Goldsmith JD, et al. A mouse model of Clostridium difficile-associated disease. Gastroenterology 2008 ; 135 : 1984–1992. [CrossRef] [PubMed] [Google Scholar]
  9. Reeves AE, Koenigsknecht MJ, Bergin IL, Young VB. Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infect Immun 2012 ; 80 : 3786–3794. [CrossRef] [PubMed] [Google Scholar]
  10. Etienne-Mesmin L, Chassaing B, Adekunle O, et al. Toxin-positive Clostridium difficile latently infect mouse colonies and protect against highly-pathogenic C. difficile. Gut 2017; pii : gutjnl-2016-313510. [Google Scholar]
  11. Etienne-Mesmin L, Chassaing B, Adekunle O, et al. Genome sequence of a toxin-positive Clostridium difficile strain isolated from murine feces. Genome Announc 2017; 5 : pii : e00088–17. [Google Scholar]
  12. Nagaro KJ, Phillips ST, Cheknis AK, et al. Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile. Antimicrob Agents Chemother 2013 ; 57 : 5266–5270. [CrossRef] [PubMed] [Google Scholar]
  13. Gerding DN, Meyer T, Lee C, et al. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. JAMA 2015 ; 313 : 1719–1727. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.